$0.94 EPS Expected for LHC Group, Inc. (LHCG) This Quarter
Wall Street brokerages expect that LHC Group, Inc. (NASDAQ:LHCG) will post earnings of $0.94 per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings. The highest EPS estimate is $0.98 and the lowest is $0.92. LHC Group reported earnings of $0.64 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 46.9%. The company is expected to announce its next earnings results on Monday, November 5th.
On average, analysts expect that LHC Group will report full year earnings of $3.52 per share for the current fiscal year, with EPS estimates ranging from $3.46 to $3.58. For the next year, analysts expect that the company will post earnings of $4.17 per share, with EPS estimates ranging from $4.09 to $4.26. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that cover LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 1st. The health services provider reported $0.84 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.06. LHC Group had a return on equity of 8.33% and a net margin of 3.75%. The firm had revenue of $502.00 million during the quarter, compared to the consensus estimate of $509.03 million. During the same quarter in the previous year, the business earned $0.63 earnings per share. The firm’s quarterly revenue was up 95.0% compared to the same quarter last year.
In other LHC Group news, COO Donald Dwayne Stelly sold 3,307 shares of the business’s stock in a transaction dated Monday, June 11th. The stock was sold at an average price of $79.76, for a total transaction of $263,766.32. Following the transaction, the chief operating officer now owns 109,145 shares in the company, valued at $8,705,405.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Jeff Reibel sold 1,921 shares of the business’s stock in a transaction dated Monday, August 20th. The stock was sold at an average price of $94.12, for a total value of $180,804.52. Following the transaction, the senior vice president now owns 8,125 shares in the company, valued at approximately $764,725. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,984 shares of company stock worth $718,297. 6.80% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently modified their holdings of LHCG. Wells Fargo & Company MN lifted its stake in shares of LHC Group by 99.4% during the first quarter. Wells Fargo & Company MN now owns 204,363 shares of the health services provider’s stock worth $12,581,000 after purchasing an additional 101,854 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of LHC Group by 2.4% in the first quarter. Rhumbline Advisers now owns 38,940 shares of the health services provider’s stock worth $2,397,000 after acquiring an additional 919 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of LHC Group in the first quarter worth about $105,000. Summit Global Investments acquired a new position in shares of LHC Group in the first quarter worth about $585,000. Finally, Victory Capital Management Inc. lifted its stake in shares of LHC Group by 7.1% in the first quarter. Victory Capital Management Inc. now owns 18,770 shares of the health services provider’s stock worth $1,156,000 after acquiring an additional 1,237 shares in the last quarter. Institutional investors own 87.08% of the company’s stock.
LHCG stock traded down $1.25 during trading on Monday, reaching $98.05. 209,976 shares of the stock traded hands, compared to its average volume of 189,744. LHC Group has a 52-week low of $58.65 and a 52-week high of $100.90. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.18. The company has a market cap of $3.11 billion, a PE ratio of 40.52, a price-to-earnings-growth ratio of 1.56 and a beta of 0.52.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Article: What does RSI mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.